Industry landscapes
The companies, capital and talent shaping telehealth and remote care in London. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
11 of 344 tracked companies have open roles.
88 of 344 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 214 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 52.6% of disclosed capital, while 74.4% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $132.5M | 31 | 18 |
| 2017 | $91.59M | 24 | 17 |
| 2018 | $50.85M | 29 | 19 |
| 2019 | $636.77M | 35 | 23 |
| 2020 | $272.12M | 46 | 30 |
| 2021 | $208.82M | 21 | 22 |
| 2022 | $144.63M | 18 | 21 |
| 2023 | $150.18M | 17 | 18 |
| 2024 | $40.81M | 14 | 8 |
| 2025 | $93.41M | 5 | 8 |
Share of all disclosed company funding.
243 recorded rounds since 2016
Recorded participation in telehealth and remote care company rounds since 2016.
Backed by Kinnevik and Public Investment Fund and others.
Backed by VNV Global.
Backed by Temasek and Sofina and others.
Participating investors were not recorded in this snapshot.
Backed by White Star Capital and Novator Partners and others.
Backed by Kinnevik and VNV Global.
Backed by Index Ventures and Headline and others.
Backed by OMERS and Index Ventures and others.
Backed by MTIP and Wellington Partners Venture Capital and others.
Backed by HPE Growth.
Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.
Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.
FY2025 · company accounts; aggregate reporting threshold not met · 2 reporting entities from 128 eligible matches.
Sum of reporting-entity revenue; not London market sales.
Combined result for the same cohort.
Combined net income ÷ combined revenue.
The middle covered reporting entity.
None of 2 covered entities.
Share of covered revenue from the five largest entities.
Reported cohort totals by year; coverage is stated for every period.
Bar height shows revenue. Changes in coverage can affect totals.
FY2025 · 2 reporting entities
Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.
| Company / reporting entity | Revenue | Net profit / loss | Net margin | Revenue growth | Total assets |
|---|---|---|---|---|---|
| Oviva ↗09667784 | £40.0m | £9.3m | +23.4% | — | — |
| 360 Lifestyle Support Network ↗13269569 | £0.1m | £0.0m | 0.0% | — | — |
Explore full company accounts and filings.
Choose “View accounts” to inspect an available company preview.
Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.
| Industry | Covered / eligible | Revenue total | Median revenue | Net profit / loss | Aggregate margin | Profitable share | Overlap |
|---|
Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.
Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.
The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.
Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.
How the London companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
12 of the 344 companies on this page carry a measured traffic record (3.5%); these are the largest of those, by monthly visits. The median among them is 721,295 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| Doktorabcdoktorabc.com | 3,053,124 | 49 | 83.5% |
| MedExpressmedexpress.co.uk | 2,764,662 | 51 | 94.1% |
| Animaanimahealth.com | 1,554,278 | 43 | 95.7% |
| Zavazavamed.com | 1,299,535 | 64 | 82.8% |
| Numannuman.com | 825,826 | 44 | 90.8% |
| HealthUnlockedhealthunlocked.com | 799,747 | 57 | 66.8% |
| Doctifydoctify.com | 642,843 | 53 | 59.7% |
| Peanutpeanut-app.io | 500,818 | 54 | 76.1% |
| Zestyzesty.co.uk | 256,028 | 18 | 84% |
| Fernarztfernarzt.com | 87,984 | 49 | 81.1% |
Visits and authority are third-party web estimates, not company-reported figures.
70 of these companies (20.3%) publish at least one Android app — 111 apps in all, carrying 35.1M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| NHS AppNHS Choices | 22.6M | 3.4 | Medical |
| NHS Couch to 5KNHS Choices | 3M | 4.9 | Health & Fitness |
| Peanut AppPeanut | 2.4M | 3.9 | Social |
| NHS Weight Loss PlanNHS Choices | 1.9M | — | Health & Fitness |
| NHS Food ScannerNHS Choices | 987.7K | — | Health & Fitness |
| NHS Active 10 Walking TrackerNHS Choices | 741.4K | 4.3 | Health & Fitness |
| Oviva Direkt: Gesund AbnehmenOviva | 485.5K | — | Medical |
| NHS Quit SmokingNHS Choices | 483.9K | 5 | Health & Fitness |
| OvivaOviva | 395.3K | 4.6 | Medical |
| Baby2Body: Pregnancy WellnessBaby2Body | 368.1K | 4.3 | Health & Fitness |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q4–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Online Health Information | 16 | 32.6M | NHS App 22.6M | |
| Healthcare Booking Platforms | 72 | 32M | NHS Couch to 5K 3M | |
| Online Mom & Baby Care | 2 | 2.8M | Peanut App 2.4M | |
| Fitness & Wellness Tech | 8 | 881.5K | Oviva Direkt: Gesund Abnehmen 485.5K | |
| Healthcare It | 55 | 824.8K | AXA Doctor At Hand 252.6K | |
| Local Services | 5 | 112.3K | PawSquad - Vet in your Pocket 90.5K | |
| Employee Health It | 6 | 42.5K | Koa Care 360 by Koa Health 26.5K | |
| Wearable Technology | 17 | 32.7K | Atom5 6.5K |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 85 of 111 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
11 companies hiring · $1.89B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Invested USD 100m for a 13 percent ownership stake in Oviva, a leading profitable European provider of digital care for weight-related and chronic illnesses.
Digital health startup Numan has raised $57 million to support its international expansion, driven by rising demand for weight loss medications.
Perci Health has closed a £3 million round, doubling its original target of £1.5m and raising a total of £7.7m in funding to support its plan to scale its AI-powered virtual cancer clinic.
Hims & Hers Health announced Tuesday it will acquire European telehealth platform Zava.
Huma’s latest acquisition follow the purchase of GP online consultation and digital triage start-up eConsult for an undisclosed amount in October 2024.
Health Hero Network (Redwood City, California) said it has secured $16 million in an oversubscribed Series B financing to underwrite ongoing new product development and marketing for its Health Buddy System.
The new funding, which values Nodal at $15 million, will be directed towards refining the platform’s technology and strengthening partnerships with fertility clinics.
The eConsult acquisition follows Huma’s strategic acquisition of iPlato, a UK based provider of screening, appointment booking, medicines management and communication tools installed in the majority of UK GP practices.
Mobihealth raised $0.8 million
The AU$49m market-cap company posted a loss in its most recent financial year of UK£5.1m and a latest trailing-twelve-month loss of UK£2.1m shrinking the gap between loss and breakeven.
Top 6 categories among 26 recorded events in the 24-month window.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| hims & hers→Zava ↗ | Completed | 2026-02-20 | Not stated in snapshot |
| Huma Therapeutics→eConsult ↗ | Completed | 2025-05-19 | Not stated in snapshot |
| huma→iPLATO ↗ | Announced | 2024-10-02 | Not stated in snapshot |
| Eli Lilly and Company→Aparito ↗ | Completed | 2024-07-15 | Not stated in snapshot |
| Babylon→Alkuri Global | Announced | 2024-03-03 | $3.6B |
| maven→Naytal ↗ | Completed | 2024-02-28 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
Recorded hiring and workforce signals from the available source snapshot.
No repeated job title is supported by this snapshot.
0 tracked postings mention remote work.
| Company | Open roles |
|---|---|
| Zava ↗ | 4 |
| Circadia ↗ | 3 |
| Phlo ↗ | 2 |
| Yokeru ↗ | 2 |
| Oviva ↗ | 2 |
| Happio ↗ | 1 |
| Neural Foundry UK ↗ | 1 |
| Cardiolyse ↗ | 1 |
| Company | Employees |
|---|---|
| NHS Choices ↗ | 7,997 |
| Oviva ↗ | 245 |
| HeliosX ↗ | 191 |
| Lifted ↗ | 90 |
| Phlo ↗ | 49 |
| TestCard ↗ | 39 |
| Sava ↗ | 34 |
| Numan ↗ | 17 |
192 founders and chief executives across 136 companies.
Numan Com, ex-Personal, ex-Togethera And Upshot, King's College London, U. of London, 2002
Ex-McKinsey. ETH Zurich MS 2005, PhD 2007
Ex-Athens Medical Grοup, Euroclinic Group, The Monitor Group · MIT Sloan School of Management MBA 2004
CTO Kamet & Melijoe.com, Novactive Canada, Sedona. University of Rennes I DUT 2003, University of Corsica Pascal Paoli & Polytechnic University of…
Ex-Goldman Sachs, Altice Capital Enterprises, KKR, Morgan Stanley. The London School of Economics and Political Science BSc 2008
Ex-The Ortus Club · Imperial College London MEng
Ex-CEO Alpha, Healthways, World Health Organization, McKinsey. University of Cambridge MA 1996, UCL BS 1999
CoMind, Everna, Resi. The King's School, Canterbury 1999, University of Oxford 2002
Ex-Expert Health, MSC, Harvard International, ETF Group Deutschland. Humboldt University of Berlin 2000, HEC Paris MBA 2004
Ex-HM Treasur. University of Cambridge 2015, 2018
Managing Director Universal Pharmacy, JCI Glasgow, HSBC, Royal Bank of Scotland. LIBF 2015, University of Glasgow 2004
Apricity Fertility, ex-Apricity, ex-Kamet, HEC School of Management, 1999
39 profiles with education records.
12 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
52,577 papers in the recorded worldwide scope.
Tone counts: 46,211 positive · 2,661 neutral · 3,705 negative.
Landmark: Virtually Perfect? Telemedicine for Covid-19
Landmark: Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review
Landmark: The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
Common problems researchers identify · 0121.6% of this theme group
Researchers highlight challenges in implementing telemedicine for chronic disease management and emergency care.
Telemedicine (1,220) · Health care (617) · Medical emergency (131) · Teledermatology (45)
Adopting Telemedicine for the Self-Management of Hypertension: Systematic Review
Telemedicine: The Status and Development Prospects
| Year | Share index |
|---|---|
| 2022 | 623.6 |
| 2023 | 559.2 |
| 2024 | 594.8 |
| 2025 | 321.3 |
Common problems researchers identify · 0217.7% of this theme group
Studies discuss patient and provider experiences, emphasizing obstacles to effective telehealth use.
Telehealth (928) · Telemedicine (476) · Nursing (121) · Health care (306)
Opportunities and challenges for telehealth within, and beyond, a pandemic
Patients’ and healthcare providers’ perceptions and experiences of telehealth use and online health information use in chronic disease manag
| Year | Share index |
|---|---|
| 2022 | 1645.3 |
| 2023 | 1572.6 |
| 2024 | 1320.3 |
| 2025 | 734.9 |
Common problems researchers identify · 0315.8% of this theme group
Literature points to unanswered questions in digital cardiac rehab and diabetes self‑management.
Health care (342) · MEDLINE (143) · Psychological intervention (143) · Intervention (60)
A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities
A Systematic Review of Patient-Perceived Barriers and Facilitators to the Adoption and Use of Remote Health Technology to Manage Diabetes an
| Year | Share index |
|---|---|
| 2022 | 1100.6 |
| 2023 | 1110.4 |
| 2024 | 997.5 |
| 2025 | 1316.7 |
Common problems researchers identify · 0414.8% of this theme group
Analyses reveal disparities and operational hurdles when mental health services shifted online during COVID‑19.
Pandemic (638) · Telehealth (374) · Telemedicine (386) · Health care (318)
The Transition of Academic Mental Health Clinics to Telehealth During the COVID-19 Pandemic
Telemedicine and health disparities: Association between patient characteristics and telemedicine, in-person, telephone and message-based ca
| Year | Share index |
|---|---|
| 2022 | 773.4 |
| 2023 | 558.9 |
| 2024 | 328.9 |
| 2025 | 209.4 |
Common problems researchers identify · 0514.2% of this theme group
Research uncovers inequities in access and outcomes linked to mHealth and eHealth adoption.
Digital health (405) · mHealth (216) · Health care (454) · eHealth (155)
Inequities in Health Care Services Caused by the Adoption of Digital Health Technologies: Scoping Review
Improving Healthcare Access through Digital Health: The Use of Information and Communication Technologies
| Year | Share index |
|---|---|
| 2022 | 105.3 |
| 2023 | 116.6 |
| 2024 | 115.3 |
| 2025 | 162.6 |
Common problems researchers identify · 0611.9% of this theme group
Papers examine how the pandemic exposed gaps in telemedicine access and specialty care.
Coronavirus disease 2019 (689) · 2019-20 coronavirus outbreak (183) · Severe acute respiratory syndrome coronavirus 2 (135) · Pandemic (533)
Telemedicine and health access inequalities during the COVID-19 pandemic
Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys
| Year | Share index |
|---|---|
| 2022 | 167.8 |
| 2023 | 109.8 |
| 2024 | 128.4 |
| 2025 | 58.3 |
Common problems researchers identify · 073.9% of this theme group
Reviews assess technical and clinical obstacles to delivering remote physical therapy.
Telerehabilitation (167) · Rehabilitation (137) · Physical therapy (38) · Physical medicine and rehabilitation (28)
Telerehabilitation: State-of-the-Art from an Informatics Perspective
Telerehabilitation in Subjects With Respiratory Disease: A Scoping Review
| Year | Share index |
|---|---|
| 2022 | 961.6 |
| 2023 | 935.2 |
| 2024 | 872.3 |
| 2025 | 680.4 |
Cautions · 0122.8% of this theme group
Authors evaluate potential benefits and risks of remote care for chronic conditions.
Telemedicine (793) · Health care (296) · Medical emergency (111) · Teledermatology (55)
Telemedicine Application in the Care of Diabetes Patients: Systematic Review and Meta-Analysis
Potential advantages and disadvantages of telemedicine: A literature review from the perspectives of patients, medical personnel, and hospit
| Year | Share index |
|---|---|
| 2022 | 623.6 |
| 2023 | 559.2 |
| 2024 | 594.8 |
| 2025 | 321.3 |
Cautions · 0218.1% of this theme group
Systematic reviews compare service utilization and outcomes across telehealth models.
Telehealth (626) · Telemedicine (281) · Nursing (63) · Health care (163)
The Effect of Telehealth on Hospital Services Use: Systematic Review and Meta-analysis
Comparative Systematic Review of Telehealth Delivery Models, Intervention Content, and Outcomes in Heart Failure Care
| Year | Share index |
|---|---|
| 2022 | 1645.3 |
| 2023 | 1572.6 |
| 2024 | 1320.3 |
| 2025 | 734.9 |
Cautions · 0315.6% of this theme group
Studies scrutinize the efficacy of mobile apps for medication adherence and disease management.
Psychological intervention (185) · mHealth (108) · Intervention (99) · Randomized controlled trial (87)
The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review
An Internet-Based Intervention for Cardiovascular Disease Management Integrated With Primary Care Electronic Health Records: Mixed Methods E
| Year | Share index |
|---|---|
| 2022 | 733.6 |
| 2023 | 774.6 |
| 2024 | 668.1 |
| 2025 | 843.5 |
Cautions · 0413.3% of this theme group
Analyses outline advantages, challenges, and unresolved issues of telehealth during COVID‑19.
Pandemic (329) · Telehealth (248) · Telemedicine (250) · Health care (137)
Use of Telehealth During the COVID-19 Pandemic: Scoping Review
Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic
| Year | Share index |
|---|---|
| 2022 | 773.4 |
| 2023 | 558.9 |
| 2024 | 328.9 |
| 2025 | 209.4 |
Cautions · 0513.2% of this theme group
Research highlights hesitations and barriers faced by clinicians adopting remote tools in the pandemic.
Coronavirus disease 2019 (506) · Pandemic (358) · 2019-20 coronavirus outbreak (116) · Severe acute respiratory syndrome coronavirus 2 (91)
Opportunities for using telemedicine based on the COVID-19 pandemic
Exploring Ophthalmologists’ Adoption of Telemedicine during the COVID-19 Pandemic: A Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 779.6 |
| 2023 | 545.9 |
| 2024 | 334.0 |
| 2025 | 184.6 |
Cautions · 0611.1% of this theme group
Reviews discuss mixed evidence on how wearables and eHealth affect patient results.
Digital health (157) · Health care (269) · Wearable computer (48) · eHealth (58)
Perception, willingness, and practices of telemedicine in patients with chronic diseases: implication of digital health in patients' perspec
An impact of digital technologies on healthcare and patient outcomes: A review
| Year | Share index |
|---|---|
| 2022 | 108.2 |
| 2023 | 122.3 |
| 2024 | 122.7 |
| 2025 | 178.5 |
Cautions · 075.9% of this theme group
Evidence questions the consistency of remote exercise programs for post‑acute patients.
Telerehabilitation (196) · Rehabilitation (106) · Physical therapy (84) · Physical medicine and rehabilitation (51)
The effect of telerehabilitation on improving the physical activity of patients with osteoarthritis: A systematic review
The Effectiveness of Exercise Interventions Supported by Telerehabilitation For Recently Hospitalized Adult Medical Patients: A Systematic R
| Year | Share index |
|---|---|
| 2022 | 961.6 |
| 2023 | 935.2 |
| 2024 | 872.3 |
| 2025 | 680.4 |
Opportunities · 0122.7% of this theme group
Emerging work explores remote monitoring and treatment pathways for long‑term conditions.
Telemedicine (1,191) · Health care (449) · Teledermatology (94) · Medical emergency (148)
Prospects for the use of telemedicine technologies for the prevention, treatment and dynamic monitoring of patients with chronic non-communi
Evaluating the Impact of Telemedicine on Patient Care and Health Outcomes with Data-Driven Approaches in Remote Health Monitoring Systems
| Year | Share index |
|---|---|
| 2022 | 623.6 |
| 2023 | 559.2 |
| 2024 | 594.8 |
| 2025 | 321.3 |
Opportunities · 0218.4% of this theme group
Investigations reveal promising uses of telehealth in mental illness and cancer rehabilitation.
Telehealth (973) · Telemedicine (359) · Intervention (164) · Psychological intervention (174)
A qualitative exploration of the experience and attitudes of exercise professionals using telehealth for people with mental illness
Moving Forward With Telehealth in Cancer Rehabilitation: Patient Perspectives From a Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 792.2 |
| 2023 | 825.4 |
| 2024 | 707.7 |
| 2025 | 866.9 |
Opportunities · 0314.9% of this theme group
Randomized trials test digital tools that aid families caring for dementia and postoperative patients.
Psychological intervention (177) · Intervention (161) · Randomized controlled trial (113) · Mental health (93)
Supporting Family Caregivers With Technology for Dementia Home Care: A Randomized Controlled Trial
Real-Time Interactive Digital Health Care System for Postoperative Breast Cancer Patients: A Randomized Controlled Trial
| Year | Share index |
|---|---|
| 2022 | 1590.8 |
| 2023 | 1613.2 |
| 2024 | 1457.1 |
| 2025 | 1582.6 |
Opportunities · 0414.3% of this theme group
Research demonstrates real‑time health tracking using connected devices and remote monitoring platforms.
Health care (404) · Internet of Things (111) · Wearable computer (160) · Remote patient monitoring (73)
Wearable technology. Health-care solutions for a growing global population.
IoT-enabled health monitoring system for real time patient care: Design and evaluation
| Year | Share index |
|---|---|
| 2022 | 177.5 |
| 2023 | 169.3 |
| 2024 | 156.7 |
| 2025 | 159.2 |
Opportunities · 0512.5% of this theme group
Studies report increased patient satisfaction and evolving care models during COVID‑19.
Coronavirus disease 2019 (417) · Pandemic (394) · 2019-20 coronavirus outbreak (72) · Telemedicine (424)
Patient Satisfaction with Telemedicine during the COVID-19 Pandemic—A Systematic Review
Trends in telehealth and in‐person transitional care management visits during the <scp>COVID</scp> ‐19 pandemic
| Year | Share index |
|---|---|
| 2022 | 779.6 |
| 2023 | 545.9 |
| 2024 | 334.0 |
| 2025 | 184.6 |
Opportunities · 068.6% of this theme group
Evidence supports remote therapy as a viable option for post‑stroke patients and caregivers.
Telerehabilitation (395) · Rehabilitation (254) · Physical therapy (184) · Physical medicine and rehabilitation (110)
Telerehabilitation—A Viable Option for the Recovery of Post-Stroke Patients
Telerehabilitation for Family Caregivers of Stroke Survivors: A Systematic Review and Meta-Analysis
| Year | Share index |
|---|---|
| 2022 | 961.6 |
| 2023 | 935.2 |
| 2024 | 872.3 |
| 2025 | 680.4 |
Opportunities · 078.6% of this theme group
Reviews highlight effective mHealth applications for self‑management of COPD, diabetes, and hypertension.
mHealth (281) · Digital health (133) · eHealth (98) · Psychological intervention (127)
Using a mobile health application to support self-management in COPD: a qualitative study
Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis
| Year | Share index |
|---|---|
| 2022 | 105.3 |
| 2023 | 116.6 |
| 2024 | 115.3 |
| 2025 | 162.6 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Promising | 33.1% | 36.8% |
| Problem-identifying | 26.6% | 9.7% |
| Descriptive | 20.8% | 17.9% |
| Cautionary | 8.1% | 4.3% |
| Breakthrough | 6.2% | 26.3% |
| Comparative | 4.8% | 4.0% |
| Critical | 0.5% | 0.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillancemHealth for mental health: Integrating smartphone technology in behavioral healthcare. | 1,984 | 4.2% | 995 (50.2%) | 4.2% |
| Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media | 60 | 0.13% | 29 (48.3%) | 0.13% |
| Bias & fairnessEvaluating and mitigating unfairness in multimodal remote mental health assessments | 8 | 0.02% | 3 (37.5%) | 0.02% |
| Energy & datacenter footprintSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re | 3 | 0.01% | 1 (33.3%) | 0.01% |
| Carbon & emissions of computeSustainable AI-Enabled UAV Healthcare Logistics: Environmental, Social, and Governance Implications from a PRISMA-ScR Re | 2 | 0.0% | 1 (50.0%) | 0.0% |
| Labour & data workCOVID-19 ends longest employment expansion in CES history, causing unprecedented job losses in 2020 | 2 | 0.0% | 0 (0.0%) | 0.0% |
| Concentration of compute powerDemonopolizing Medical Knowledge | 2 | 0.0% | 1 (50.0%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
| Hardware, e-waste & supply chain | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.
Compare demand signals in London’s newsflow with the telehealth and remote care categories mapped to each signal.
Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.
The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.
Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.
Swipe horizontally to compare all columns →
| Signal family | Signal percentile | Supply percentile | Relative gap | Gap (points) | Signal share vs prior year |
|---|---|---|---|---|---|
| Air pollution ↗Environmental Driver | 45.8 | 0.0 | +45.8 | -1.2% | |
| Mental health ↗Disease Burden | 50.0 | 33.3 | +16.7 | — | |
| Ageing & elder care ↗Disease Burden | 66.7 | 83.3 | -16.6 | +17.4% | |
| Diabetes, hypertension & cardiac burden ↗Disease Burden | 25.0 | 83.3 | -58.3 | — | |
| Cancer burden ↗Disease Burden | 41.7 | — | No matching category | — | -27.1% |
| Maternal & child health ↗Disease Burden | 33.3 | — | No matching category | — | +5.6% |
| Layoffs & income shocks ↗Spending Pressure | 87.5 | — | No matching category | — | +10.1% |
Showing all 7 signals. Select a family for its history and mapped categories.
All 12 city readings for these demand families in the comparison geography. London is highlighted.
Each city’s reading is a share of its own coverage. Rows cover all of the United Kingdom for this page's signal families; London is marked.
Cancer burden · Diabetes, hypertension & cardiac burden · Layoffs & income shocks
Ageing & elder care · Mental health · Maternal & child health
Maternal & child health · Mental health · Layoffs & income shocks
Mental health · Cancer burden · Layoffs & income shocks
Maternal & child health · Cancer burden · Ageing & elder care
Mental health · Maternal & child health · Air pollution
Layoffs & income shocks · Cancer burden · Mental health
Cancer burden · Mental health · Layoffs & income shocks
Layoffs & income shocks · Cancer burden · Air pollution
Maternal & child health · Layoffs & income shocks · Cancer burden
Cancer burden · Layoffs & income shocks · Maternal & child health
Maternal & child health · Layoffs & income shocks · Cancer burden
Sustained air-quality stress can pull respiratory and cardiac care demand with it.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 15 | 5.84 |
| 2024Q4 | 24 | 10.23 |
| 2025Q1 | 32 | 12.07 |
| 2025Q2 | 29 | 12.05 |
| 2025Q3 | 54 | 17.75 |
| 2025Q4 | 20 | 8.29 |
| 2026Q1 | 17 | 5.46 |
Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 7 | 2.73 |
| 2024Q4 | 12 | 5.12 |
| 2025Q1 | 9 | 3.39 |
| 2025Q2 | 9 | 3.74 |
| 2025Q3 | 46 | 15.12 |
| 2025Q4 | 9 | 3.73 |
| 2026Q1 | 34 | 10.93 |
An ageing base can shift demand toward geriatric, home and chronic care.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 14 | 5.45 |
| 2024Q4 | 16 | 6.82 |
| 2025Q1 | 19 | 7.16 |
| 2025Q2 | 11 | 4.57 |
| 2025Q3 | 42 | 13.81 |
| 2025Q4 | 9 | 3.73 |
| 2026Q1 | 12 | 3.86 |
Chronic cardiometabolic burden can turn into decades of management demand per patient.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 20 | 7.79 |
| 2024Q4 | 6 | 2.56 |
| 2025Q1 | 9 | 3.39 |
| 2025Q2 | 15 | 6.23 |
| 2025Q3 | 17 | 5.59 |
| 2025Q4 | 17 | 7.05 |
| 2026Q1 | 12 | 3.86 |
Cancer burden can pull screening, diagnostics and oncology capacity demand.
This signal has no matching category in the page’s telehealth and remote care market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 34 | 13.24 |
| 2024Q4 | 33 | 14.07 |
| 2025Q1 | 83 | 31.3 |
| 2025Q2 | 60 | 24.93 |
| 2025Q3 | 26 | 8.55 |
| 2025Q4 | 53 | 21.98 |
| 2026Q1 | 42 | 13.5 |
Maternal and child burden can pull immunisation, nutrition and pediatric care demand.
This signal has no matching category in the page’s telehealth and remote care market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 22 | 8.57 |
| 2024Q4 | 14 | 5.97 |
| 2025Q1 | 19 | 7.16 |
| 2025Q2 | 7 | 2.91 |
| 2025Q3 | 28 | 9.2 |
| 2025Q4 | 12 | 4.98 |
| 2026Q1 | 28 | 9.0 |
Layoff cycles can pull discretionary spend back toward value offerings.
This signal has no matching category in the page’s telehealth and remote care market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 54 | 21.03 |
| 2024Q4 | 61 | 26.01 |
| 2025Q1 | 84 | 31.68 |
| 2025Q2 | 50 | 20.77 |
| 2025Q3 | 84 | 27.61 |
| 2025Q4 | 43 | 17.83 |
| 2026Q1 | 109 | 35.03 |
London telehealth and remote care coverage
BMJ
610 citations in the snapshot
The Lancet Infectious Diseases
455 citations in the snapshot
Clinical Infectious Diseases
252 citations in the snapshot
Clinical Infectious Diseases
241 citations in the snapshot
London coverage of this page's demand families
| Keyword | Recent articles | Prior articles | Share change |
|---|---|---|---|
| daycare vaccination rules | 40 | 8 | 345.9% |
| vaccine requirements for minors | 37 | 8 | 312.5% |
| childhood immunization laws | 40 | 10 | 256.7% |
| pediatric catch-up vaccinations | 40 | 11 | 224.3% |
| pollution monitoring | 22 | 15 | 30.8% |
| air quality standards | 26 | 19 | 22.0% |
Share changes describe coverage in the stated comparison periods, not search demand or market size.
Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 3 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗